Amy Peterson
Overview
Amy Peterson received an average of $2M in total compensation, including $394K in salary, at CytomX Therapeutics from 2019 to 2022. Amy Peterson also received an average of $3M at BeiGene, Ltd. from 2017 to 2019.
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
CytomX TherapeuticsFormer President and Chief Operating Officer
CytomX TherapeuticsPresident, Chief Operating Officer
CytomX TherapeuticsPresident, Chief Operating Officer
CytomX TherapeuticsPresident, Chief Operating Officer
BeiGene, Ltd.Former Chief Medical Officer, Immuno, oncology
BeiGene, Ltd.Former Chief Medical Officer, Immuno, oncology
BeiGene, Ltd.Chief Medical Officer Immuno, oncology
Source: SEC filings on April 27, 2023, April 27, 2022, April 28, 2020, and April 30, 2018.
Related executives
We found 16 more executives who work or worked at CytomX Therapeutics and BeiGene, Ltd..
Sean McCarthy
CytomX Therapeutics
Chief Executive Officer
Marcia Belvin
CytomX Therapeutics
Chief Scientific Officer
Jeff Landau
CytomX Therapeutics
Senior Vice President and Chief Business Officer
Carlos Campoy
CytomX Therapeutics
Chief Financial Officer
Lloyd Rowland
CytomX Therapeutics
Senior Vice President,
Alison Hannah
CytomX Therapeutics
Chief Medical Officer
John Oyler
BeiGene, Ltd.
Chief Executive Officer
Xiaobin Wu
BeiGene, Ltd.
General Manager of China and President
News
CytomX Therapeutics CEO Sean McCarthy's 2022 pay falls 31% to $3M
April 27, 2023
CytomX Therapeutics CEO Sean McCarthy's 2021 pay jumps 52% to $4.3M
April 27, 2022
BeiGene, Ltd. CEO John Oyler's 2019 pay falls 55% to $13M
April 28, 2020
BeiGene, Ltd. CEO John Oyler's 2018 pay jumps 171% to $28M
April 29, 2019